Indietro
DABIGATRAN Sandoz caps 110 mg
Sandoz Pharmaceuticals AG
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | |
|---|---|---|---|---|---|---|
DABIGATRAN Sandoz caps 110 mg 60 pceSandoz Pharmaceuticals AG | 1032197 | CHF 60.95 | Cat. B | SL / 10% | ||
DABIGATRAN Sandoz caps 110 mg 180 pceSandoz Pharmaceuticals AG | 1032199 | CHF 150.10 | Cat. B | SL / 10% |
Articoli alternativi senza carenza di approvvigionamento segnalata
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | Relazione farmaceutica | |
|---|---|---|---|---|---|---|---|
PRADAXA caps 110 mg 60 pceBoehringer Ingelheim (Schweiz) GmbH | 7361787 | CHF 65.15 | Cat. B | SL / 10% | Equivalente | ||
PRADAXA caps 110 mg 3 x 60 pceBoehringer Ingelheim (Schweiz) GmbH | 7361793 | CHF 162.70 | Cat. B | SL / 10% | Equivalente | ||
DABIGATRAN Spirig HC caps 110 mg 60 pceSpirig HealthCare AG | 1098626 | CHF 60.95 | Cat. B | SL / 10% | Equivalente | ||
DABIGATRAN Spirig HC caps 110 mg 180 pceSpirig HealthCare AG | 1098628 | CHF 150.10 | Cat. B | SL / 10% | Equivalente | ||
PRADAXA caps 150 mg 60 pceBoehringer Ingelheim (Schweiz) GmbH | 7361801 | CHF 65.15 | Cat. B | SL / 10% | Forma | ||
PRADAXA caps 150 mg 3 x 60 pceBoehringer Ingelheim (Schweiz) GmbH | 7361818 | CHF 162.70 | Cat. B | SL / 10% | Forma | ||
DABIGATRAN Sandoz caps 150 mg 60 pceSandoz Pharmaceuticals AG | 1032200 | CHF 60.95 | Cat. B | SL / 10% | Forma | ||
DABIGATRAN Sandoz caps 150 mg 180 pceSandoz Pharmaceuticals AG | 1032202 | CHF 150.10 | Cat. B | SL / 10% | Forma | ||
DABIGATRAN Spirig HC caps 150 mg 60 pceSpirig HealthCare AG | 1098629 | CHF 60.95 | Cat. B | SL / 10% | Forma | ||
DABIGATRAN Spirig HC caps 150 mg 180 pceSpirig HealthCare AG | 1098631 | CHF 150.10 | Cat. B | SL / 10% | Forma |